Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The Advantage of Bactericidal Drugs in the Treatment of Infection.

Literature DB >> 15265451

The Advantage of Bactericidal Drugs in the Treatment of Infection.

Jeffrey Alder¹, Barry Eisenstein.

Abstract

Year: 2004 PMID： 15265451 DOI： 10.1007/s11908-004-0042-1

Source DB: PubMed Journal: Curr Infect Dis Rep ISSN： 1523-3847 Impact factor: 3.725

× No keyword cloud information.

20 in total

1. In vitro bactericidal activity of daptomycin against staphylococci.

Authors: Peter C Fuchs; Arthur L Barry; Steven D Brown
Journal: J Antimicrob Chemother Date: 2002-03 Impact factor: 5.790

2. Mechanism of the antimicrobial drug trimethoprim revisited.

Authors: E P Quinlivan; J McPartlin; D G Weir; J Scott
Journal: FASEB J Date: 2000-12 Impact factor: 5.191

3. Treatment of pneumococcic meningitis with penicillin compared with penicillin plus aureomycin; studies including observations on an apparent antagonism between penicillin and aureomycin.

Authors: M H LEPPER; H F DOWLING
Journal: AMA Arch Intern Med Date: 1951-10

Review 4. Mechanisms of action of antimicrobials: focus on fluoroquinolones.

Authors: D C Hooper
Journal: Clin Infect Dis Date: 2001-03-15 Impact factor: 9.079

5. Pharmacodynamic assessment of gatifloxacin against Streptococcus pneumoniae.

Authors: H M Mattoes; M Banevicius; D Li; C Turley; D Xuan; C H Nightingale; D P Nicolau
Journal: Antimicrob Agents Chemother Date: 2001-07 Impact factor: 5.191

Review 6. Oxazolidinone antibiotics.

Authors: D J Diekema; R N Jones
Journal: Lancet Date: 2001-12-08 Impact factor: 79.321

7. Synergy. Should it determine antibiotic selection in neutropenic patients?

Authors: G P Bodey
Journal: Arch Intern Med Date: 1985-11

8. A controlled study of intrathecal antibiotic therapy in gram-negative enteric meningitis of infancy. Report of the neonatal meningitis cooperative study group.

Authors: G H McCracken; S G Mize
Journal: J Pediatr Date: 1976-07 Impact factor: 4.406

Review 9. Mechanism of action of spiramycin and other macrolides.

Authors: A Brisson-Noël; P Trieu-Cuot; P Courvalin
Journal: J Antimicrob Chemother Date: 1988-07 Impact factor: 5.790

10. Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the Hershey Medical Center.

Authors: Bulent Bozdogan; Duygu Esel; Cynthia Whitener; Frederick A Browne; Peter C Appelbaum
Journal: J Antimicrob Chemother Date: 2003-10-16 Impact factor: 5.790

13 in total

1. Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.

Authors: Stefanie Heller; Laurenz Kellenberger; Stuart Shapiro
Journal: Antimicrob Agents Chemother Date: 2007-03-26 Impact factor: 5.191

2. Arylthiazole antibiotics targeting intracellular methicillin-resistant Staphylococcus aureus (MRSA) that interfere with bacterial cell wall synthesis.

Authors: Islam Eid; Mohamed M Elsebaei; Haroon Mohammad; Mohamed Hagras; Christine E Peters; Youssef A Hegazy; Bruce Cooper; Joe Pogliano; Kit Pogliano; Hamada S Abulkhair; Mohamed N Seleem; Abdelrahman S Mayhoub
Journal: Eur J Med Chem Date: 2017-08-18 Impact factor: 6.514

3. Repurposing the Antiamoebic Drug Diiodohydroxyquinoline for Treatment of Clostridioides difficile Infections.

Authors: Nader S Abutaleb; Mohamed N Seleem
Journal: Antimicrob Agents Chemother Date: 2020-05-21 Impact factor: 5.191

4. Synthesis and antibacterial evaluation of a novel series of synthetic phenylthiazole compounds against methicillin-resistant Staphylococcus aureus (MRSA).

Authors: Haroon Mohammad; P V Narasimha Reddy; Dennis Monteleone; Abdelrahman S Mayhoub; Mark Cushman; Mohamed N Seleem
Journal: Eur J Med Chem Date: 2015-03-07 Impact factor: 6.514

5. In silico identification of two peptides with antibacterial activity against multidrug-resistant Staphylococcus aureus.

Authors: Linda B Oyama; Hamza Olleik; Ana Carolina Nery Teixeira; Matheus M Guidini; James A Pickup; Brandon Yeo Pei Hui; Nicolas Vidal; Alan R Cookson; Hannah Vallin; Toby Wilkinson; Denise M S Bazzolli; Jennifer Richards; Mandy Wootton; Ralf Mikut; Kai Hilpert; Marc Maresca; Josette Perrier; Matthias Hess; Hilario C Mantovani; Narcis Fernandez-Fuentes; Christopher J Creevey; Sharon A Huws
Journal: NPJ Biofilms Microbiomes Date: 2022-07-14 Impact factor: 8.462

6. Anti-biofilm activity and synergism of novel thiazole compounds with glycopeptide antibiotics against multidrug-resistant staphylococci.

Authors: Haroon Mohammad; Abdelrahman S Mayhoub; Mark Cushman; Mohamed N Seleem
Journal: J Antibiot (Tokyo) Date: 2014-10-15 Impact factor: 2.649

7. Clinical experience with daptomycin in Europe: the first 2.5 years.

Authors: Armando Gonzalez-Ruiz; Andres Beiras-Fernandez; Hans Lehmkuhl; R Andrew Seaton; Juergen Loeffler; Ricardo L Chaves
Journal: J Antimicrob Chemother Date: 2011-01-25 Impact factor: 5.790

8. Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureus.

Authors: Mohamed F Mohamed; Ahmed Abdelkhalek; Mohamed N Seleem
Journal: Sci Rep Date: 2016-07-11 Impact factor: 4.379

9. The joint in vitro action of polymyxin B and miconazole against pathogens associated with canine otitis externa from three European countries.

Authors: Silvia Pietschmann; Michael Meyer; Michael Voget; Michael Cieslicki
Journal: Vet Dermatol Date: 2013-05-31 Impact factor: 1.589

10. The rumen microbiome: an underexplored resource for novel antimicrobial discovery.

Authors: Linda B Oyama; Susan E Girdwood; Alan R Cookson; Narcis Fernandez-Fuentes; Florence Privé; Hannah E Vallin; Toby J Wilkinson; Peter N Golyshin; Olga V Golyshina; Ralf Mikut; Kai Hilpert; Jennifer Richards; Mandy Wootton; Joan E Edwards; Marc Maresca; Josette Perrier; Fionnuala T Lundy; Yu Luo; Mei Zhou; Matthias Hess; Hilario C Mantovani; Christopher J Creevey; Sharon A Huws
Journal: NPJ Biofilms Microbiomes Date: 2017-12-01 Impact factor: 7.290